Corcept Therapeutics Incorporated (CORT) Hits Fresh High: Is There Still Room to Run?

Have you been paying attention to shares of Corcept Therapeutics (CORT) ? Shares have been on the move with the stock up 26.8% over the past month. The stock hit a new 52-week high of $39.75 in the previous session. Corcept Therapeutics has gained 19.1% since the start of the year compared to the 7.1% move for the Zacks Medical sector and the -1.9% return for the Zacks Medical - Drugs industry. What's Driving the Outperformance? The stock has a great record of positive earnings surprises, as it hasn't misse ...